Literature DB >> 2226706

Plasmodium falciparum: ATP/ADP transport across the parasitophorous vacuolar and plasma membranes.

I Choi1, R B Mikkelsen.   

Abstract

Previous studies have shown that ATP is required for the growth of the intracellular parasite, Plasmodium, outside its host cell, the erythrocyte, and that bongkrekic acid, an inhibitor of mitochondrial ATP/ADP transporter, inhibits intraerythrocytic Plasmodium maturation. We have characterized ATP/ADP transport of Plasmodium falciparum, isolated by either immune lysis or N2-cavitation. [3H]ATP uptake was due to ATP/ADP exchange since ADP efflux was dependent on exogenous ATP in an approximate 1:1 stoichiometry and both ATP influx and ADP efflux were equally inhibited by atractyloside (Ki = 100 nM). ATP uptake was not inhibited by the nucleoside transport inhibitor, nitrobenzylthioinosine. Conversely, adenosine and hypoxanthine transport were insensitive to atractyloside. ATP influx was characterized by a Km = 0.14 mM and Vmax = 1.2 nmol ATP/min/10(6) cells. Substrate specificity studies for nucleotide-induced ADP efflux indicated a preference for an adenosine ring and triphosphate, but transport did not require a hydrolyzable phosphate bond. Protein synthesis was measured with free parasites starved of glucose. Addition of 1.0 mM ATP resulted in a 40% recovery of total protein synthetic capacity in a process inhibited by 500 nM atractyloside, suggesting that uptake of erythrocyte-derived ATP by P. falciparum may be essential for maintaining maximal rates of protein synthesis during specific stages of intra-erythrocytic parasite maturation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226706     DOI: 10.1016/0014-4894(90)90071-j

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

1.  Leishmania mexicana amazonensis: plasma membrane adenine nucleotide translocator and chemotaxis.

Authors:  S Detke; R Elsabrouty
Journal:  Exp Parasitol       Date:  2007-10-22       Impact factor: 2.011

2.  Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology.

Authors:  J A Silverman; M L Hayes; B J Luft; K A Joiner
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

Authors:  C J Beckers; D S Roos; R G Donald; B J Luft; J C Schwab; Y Cao; K A Joiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 4.  Purine import into malaria parasites as a target for antimalarial drug development.

Authors:  I J Frame; Roman Deniskin; Avish Arora; Myles H Akabas
Journal:  Ann N Y Acad Sci       Date:  2014-11-25       Impact factor: 5.691

5.  Localization of azithromycin in Toxoplasma gondii-infected cells.

Authors:  J C Schwab; Y Cao; M R Slowik; K A Joiner
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Erythrocytic adenosine monophosphate as an alternative purine source in Plasmodium falciparum.

Authors:  María B Cassera; Keith Z Hazleton; Paul M Riegelhaupt; Emilio F Merino; Minkui Luo; Myles H Akabas; Vern L Schramm
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

Review 7.  The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs.

Authors:  Natalie Jane Spillman; Kiaran Kirk
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-08-27       Impact factor: 4.077

8.  Lack of mitochondrial MutS homolog 1 in Toxoplasma gondii disrupts maintenance and fidelity of mitochondrial DNA and reveals metabolic plasticity.

Authors:  Tamila Garbuz; Gustavo Arrizabalaga
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

9.  Transcriptome Analysis Identifies Plasmodiophora brassicae Secondary Infection Effector Candidates.

Authors:  Jiangying Tu; Matthew Waldner; Edel Pérez-López; Md Musharaf Hossain; Christopher D Todd; Anthony J Kusalik; Yangdou Wei; Peta C Bonham-Smith
Journal:  J Eukaryot Microbiol       Date:  2020-02-11       Impact factor: 3.346

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.